Patent application number | Description | Published |
20110086097 | Manufacture process for the preparation of an iron containing phosphate adsorbent - The present invention relates to a new manufacture process for producing an iron containing phosphate adsorbent, in particular to a process for manufacturing and isolating an iron(III)-based phosphate adsorbent which exhibits valuable pharmacological properties. | 04-14-2011 |
20130039984 | Manufacture process for the preparation of an iron containing phosphate adsorbent - The present invention relates to a new manufacture process for producing an iron containing phosphate adsorbent, in particular to a process for manufacturing and isolating an iron(III)-based phosphate adsorbent which exhibits valuable pharmacological properties. | 02-14-2013 |
20130252979 | PHARMACEUTICAL COMPOSITIONS, DOSAGE FORMS AND NEW FORMS OF THE COMPOUND OF MULA (I), AND METHODS OF USE THEREOF - The present invention relates to a novel crystalline anhydrous form of [(5-chlorothiophene-2-ylsulfonylcarbamoyl)-(4-(6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)phenyl)amide, potassium salt, and its use in the treatment or prevention of a condition or a disorder with platelet ADP receptor inhibition, in particular, P2Y | 09-26-2013 |
20130316018 | Manufacture process for the preparation of an iron containing phosphate adsorbent - The present invention relates to a new manufacture process for producing an iron containing phosphate adsorbent, in particular to a process for manufacturing and isolating an iron(III)-based phosphate adsorbent which exhibits valuable pharmacological properties. | 11-28-2013 |
20150246897 | Process for Manufacturing 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine - The invention discloses improved processes for manufacturing a compound, 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine, its monohydrochloride salt and intermediates thereof. | 09-03-2015 |
20150284364 | SUBSTITUTED INDOLE DERIVATIVES - The present invention relates to substituted indole derivatives, to processes for their production, to new stable forms, their use as pharmaceuticals and to pharmaceutical compositions comprising them. | 10-08-2015 |
Patent application number | Description | Published |
20080272774 | Magnetic Resonance Method for the Detection and Imaging of Susceptibility Related Magnetic Field Distortions - Disclosed are methods and apparatuses for generating susceptibility-related contrast images, as induced, e.g., by marker material interventional devices used for passive MR-guided interventions, or by particles or cells loaded with marker materials used for molecular imaging, cell-tracking or cell-labeling. Near a local magnetic field perturber a positive contrast signal emanates from local gradient compensation to form, e.g., a balanced SSFP type of echo, whereas everywhere else echoes are shifted outside of the data acquisition window. | 11-06-2008 |
20110234224 | Modification of Frequency Response Profiles of Steady State Free Precession for Magnetic Resonance Imaging (MRI) - Apparatus and methods for modification of the frequency response profile of steady-state free precession (SSFP) type of magnetic resonance imaging (MRI) sequences. Using alternating dephasing moments within succeeding radiofrequency (RF) excitation pulses, the frequency response function of SSFP sequences can be modified to different shapes such as near triangular or bell shaped. The particular response function as produced by alternating dephasing moments can be used, among others, for functional brain MRI, MR spectroscopy or spatial encoding. | 09-29-2011 |
20110234225 | Magnetic Resonance Method for Quantification of Transverse Relaxation Times - Apparatus and methods for quantification of transverse relaxation times (T | 09-29-2011 |
20120242334 | MAGNETIC RESONANCE METHOD FOR QUANTIFICATION OF MOLECULAR DIFFUSION USING DOUBLE ECHO STEADY STATE SEQUENCES - Disclosed is a magnetic resonance method for the quantification of molecular diffusion. The method uses a diffusion-weighted (dw) double echo steady state sequence (DESS). In particular, the method allows direct quantification of molecular diffusion from two steady state scans with differing diffusion weighting such as one with diffusion-weighting and preferably one without diffusion weighting. Such a quantification of molecular diffusion allows for rapid and/or quantitative measurements of physiological and/or functional parameters of living tissue. Quantitative measurements are often a prerequisite for pre-clinical and clinical research as well as for clinical trials in drug research performed at different sites. Especially for the early diagnosis of subtle or diffuse pathological changes, quantitative MR promises to have a very significant impact. | 09-27-2012 |
20140292325 | MAGNETIC RESONANCE IMAGING METHOD FOR THE QUANTIFICATION OF THE T1 AND/OR T2 RELAXATION TIMES IN A SAMPLE - A magnetic resonance imaging (MRI) method for the quantification of the longitudinal (T | 10-02-2014 |
20140303482 | MAGNETIC RESONANCE IMAGING METHOD FOR IMAGING COMPONENTS WITH SHORT TRANSVERSE RELAXATION TIMES (T2) IN A HUMAN OR AN ANIMAL HEART - A magnetic resonance imaging (MRI) method for imaging components with short transverse relaxation times (T | 10-09-2014 |